发明名称 Method for treating inflammatory conditions with mucosally administered interleukin-2
摘要 Provided herein are methods for the treatment of abnormal inflammation and inflammatory conditions comprising mucosal administration of an effective amount of an interleukin (e.g. IL-2) or a fragment or derivative thereof. Also provided herein are pharmaceutical compositions for mucosal administration for the treatment of abnormal inflammation and inflammatory conditions, the composition comprising said interleukin or fragment or derivative.
申请公布号 US9248188(B2) 申请公布日期 2016.02.02
申请号 US201113885993 申请日期 2011.11.09
申请人 BIOLINGUS IP LLC 发明人 Ko Sai Ying
分类号 A61K38/20;A61K9/00;A61K45/06;A61K9/16;A61K9/20;A61K9/48 主分类号 A61K38/20
代理机构 Wenderoth, Lind & Ponack, L.L.P. 代理人 Wenderoth, Lind & Ponack, L.L.P.
主权项 1. A method for the treatment of an inflammatory condition in a subject, the method comprising mucosally administering to the subject an effective amount of interleukin-2 (IL-2), wherein the mucosal administration is sublingual administration, and wherein the inflammatory condition is selected from arthritis, sinusitis, allergic disorders, psoriasis, acne, inflammatory bowel diseases, chronic fatigue syndrome, autoimmune disorders, Sjögren's syndrome, inflammation of the prostate, inflammation of the urinary tract, pancreatitis, vasculitis, diabetes, gout or a related condition, and menstrual pain.
地址 Hergiswil CH